Catalent Inc. (CTLT)
Россия
  • Россия
  • Украина

Catalent Inc. (CTLT)

Contact Details

14 Schoolhouse Rd, Somerset, New Jersey, USA 08873-1213
(732) 537-6200
14 Schoolhouse Rd, Somerset, New Jersey, USA 08873-1213

General Information

Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.

Contact Information

Phone(732) 537-6200
Customer Service Phone(888) 825-5249
Website 1http://www.catalent.com
FacebookFacebook
LinkedInLinkedIn
Twitter@catalentpharma
Thomson Reuters PermID5000053849

Executives

NamePositionTotal Annual CompensationYearPercent Change in Compensation
CEO, Director and President$4,911,3952015454.1%
CFO and Executive VP$2,079,515201568.0%
Divisional Senior VP$1,482,8202015
Divisional Senior VP$1,373,1182015108.1%
Divisional Senior VP$1,355,6192015198.6%

Corporate Data

Industries

  • Pharmaceutical Preparation Manufacturing

SIC Industries

  • Pharmaceutical Preparations

Company Size

Sales Volume$1.83 billion
Employees8,700

Ownership

Ticker SymbolCTLT
ExchangeNew York Stock Exchange (NYSE)
Year Founded2007

Stocks

Previous Close28.11
Open28.18
Bid27.37 x 500
Ask29.99 x 100
Day`s Range27.11 - 28.43
52-Week Range20.86 - 34.21
Average Volume (1M)491,819
Forward P/E18.62x
Trailing P/E18.14x
Beta1.37x
Market Cap.$3,500.34 Million

Financials

Period EndingDec. 31, 2015Sep. 30, 2015Jun. 30, 2015Mar. 31, 2015
Total Revenue454,900423,000510,100.1446,600
Cost of Revenue302,800301,500328,400294,400
Gross Profit152,100121,500181,700.1152,200
Research Development----
Selling General and Administrative93,00082,20086,90080,900
Depreciation and Amortization----
Other Operating Expenses5002,2005,600.15,500
Total Operating Expenses396,300385,900420,900.1380,800
Other Income/Expenses Net----
Earnings Before Interest and Taxes58,60037,10089,20065,800
Interest Expense22,30022,70022,60023,000
Income Before Tax39,80013,80062,70042,000
Income Tax Expense9,2004,900(90,800)11,200
Minority Interest----
Net Income from Continuing Ops30,6008,900153,50030,800
Discontinued Operations--(100)-
Extraordinary Items----
Effect of Accounting Changes----
Other Items100200300700
Net Income30,7009,100153,70031,500
Preferred Stock and Other Adjustments----
Net Income Applicable to Common Shares30,7009,100153,70031,500